Evidence map›Paper›PMID 28377506›Full record

ArticleThe Journal of biological chemistry2017

Heme deficiency sensitizes yeast cells to oxidative stress induced by hydroxyurea.

Amanpreet Singh, Yong-Jie Xu

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Dissecting the Cell-Killing Mechanisms of Hydroxyurea Using Spot Assays.Methods in molecular biology (Clifton, N.J.) · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. A missense mutation in themicroPublication biology · 2023
    Article
  10. Smc5/6 Complex Promotes Rad3Molecular and cellular biology · 2022
    Article
  11. Article
  12. RecQ DNA Helicase Rqh1 Promotes Rad3Molecular and cellular biology · 2020
    Article
  13. Article
  14. AMolecular and cellular biology · 2019
    Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Amanpreet SinghFrom the Department of Pharmacology and Toxicology, Boonshoft School of Medicine, Wright State University, Dayton, Ohio 45435 and.
Yong-Jie XuFrom the Department of Pharmacology and Toxicology, Boonshoft School of Medicine, Wright State University, Dayton, Ohio 45435 and yong-jie.xu@wright.edu.
New York State Department of Health · USWright State University · US

Funding

Signaling Mechanism of the DNA Replication CheckpointR01GM110132 · NIGMS · WRIGHT STATE UNIVERSITY · PI XU, YONGJIE · 2015 to 2020
$1.3M
NIGMS NIH HHS R01 GM110132
6 · The paper itself

Abstract

Hydroxyurea (HU) has a long history of clinical and scientific use as an antiviral, antibacterial, and antitumor agent. It inhibits ribonucleotide reductase and reversibly arrests cells in S phase. However, high concentrations or prolonged treatment with low doses of HU can cause cell lethality. Although the cytotoxicity of HU may significantly contribute to its therapeutic effects, the underlying mechanisms remain poorly understood. We have previously shown that HU can induce cytokinesis arrest in the

Indexed as

HemeHydroxyureaMutationOxidative StressSchizosaccharomycesSchizosaccharomyces pombe ProteinsHemeHydroxyureaSchizosaccharomyces pombe Proteinscell cyclecheckpoint controlDNA replicationhemeoxidative stressribonucleotide reductase

Identifiers

PMID28377506
PMCPMC5454094
OpenAlexW2605181786

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.